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Infections During a Randomized Trial Comparing Cyclosporine to 
FK 506 Immunosuppression in Liver Transplantation 
S. Kusne. J. Fung, M. Alessiani, M. Martin, J. Torre-Cisneros, W. Irish, L. Ondick, A. Jain. K. Abu-Elmagd, 
S. Takaya. S. Todo. and T.E. Starzl 
WE PREVIOUSLY reponed our experience of infec-
tiOUS complications occurring following liver trans-
plantation (OLT) under an experimental immunosuppres-
sive agent FK 506. I In February 1990 we initiated a 
randomized trial comparing this new drug to cyclosporine 
(eyA) in patients undergoing their first OLT. In this repon 
we analyzed the infectious complications in the first 110 
patients enrolled in this study. 
METHODS 
Patient Populabon 
Ow-actenslics of the pauent population 15 shown in Table I. The 
piUents enrolled In tlus study were considered relauvely low-nsk 
c:udidates who did not have sigruficant kidney. hean. or lung 
disease. were not human Immunodeficiency virus (HIV) or B 
befautis camers. and in whom the transplant operation was 
Ibought to be functionally adequate. There were a total of 110 
puXnts enroUed in this study between February and December 
1990.53 on eyA and 57 on FK 506. The median foUow-up was 341 
days. All patients were foUowed prospectively for infections. 
MOlt pauents had surveillance viral cultures at 2·week intervals 
for the first 2 months and monthly dunng the following 4 months. 
Other cultures were done when clinically indicated. 
immunosuppression 
Patients on CyA were given an IV dose of 4 mgfkg/d and when 
able to take oral medications. 8 m!Zlkg was administered in two 
divided doses. Patients on FK 506 were given a conunuous IV 
infusion at 0.1 mlt'klt'd and later changed to PO at 0.15 mlZ/kg 
every 12 hours. Steroid induction Included I g of methvlprednls, 
oIone and sterOId malDtenance 20 mg predrusone. Treatment of 
acute rejection Included methylpredrusolone "bolus" and/or ste-
IlJId "recvcle.·· Sterold·reslstant reJecuon was lreated wllh OKT3 
monoclonal anubody t MAb). or conversIon to FK S06 for those 
pUaents on eyA.: 
~ylaxlp and Infection Oefinitions 
We Used our prevIous definitions of infection.' and subdiVIded 
them In major c31egones tbactenal. Viral. fungal. protozoal). 
T8b1e 1. Chal'Kt8ftstlca of the Patient ~ 
CyA FI( S06 
No. Patients 53 57 
~erahl 33.'20 31:26 
"'-' age = SO Iy) 43.5 = 10.2 '2 = 11.4 
"'-an tOlIOw-uQ tdl 342 341 
~tofllw-un 1~9O 93-497 
"-ants :. 1 y fOUOW-up 22 23 ~ar SUMI/aJ 1%1 84 95 
Infections not included in the anaiysis were: bactenal sinusitis. 
cystitis. line infection without bacterenua. and localized herpes 
infection. Antimicrobial prophylaxis included 3 gld cefotax.ime or 
ceftizoxime IV together with 4 gld ampicillin for 72 hours. 2 
million Uld PO nystatin. trimethoprimisulfametholtazole 80 mgl 
400 mg PO every day. and acyclovir between 400 mg and 3200 mg 
PO for the duration of 6 months. 
StaIistic:s 
There were 37 patients who were initially lreated with CyA but 
were later conunued on FK 506. These patlents posed a problem 
for staustlcal analysis. It was felt that treaung these pauents as 
withdnwals or creallng a third ann would bias the results of the 
study. Therefore. In order not to undenrune the reasons for 
randomization. the staustical analysis was perfonned by intention 
to treat. Survival rates and infection-free rates were calculated by 
the Kaplan-Meier method. Proportions were analyzed by using 
the chi-square test of association. A P value < .05 was considered 
statlstically sigruficant. 
RESULTS 
The 110 patients enrolled in the study were prospectively 
followed for infectious complications. Twenty-two and 23 
patients treated with CyA and FK 506. respectively. were 
foUowed for more than I year. The population in the two 
groups was similar for liver diagnosis. age. and maleJ 
femaje ratio (Table I I. 
Of the 53 patients lOitially treated with Cy A. 37 failed the 
prescribed reglmen for CyA and were convened to FK 
RMSK~ The median time to the conversion was 10 days. 
Sixteen patients currently remain on CyA. For purpose of 
this study. we will refer to . 'Cy A" as all patients who were 
mitially randomized to receive eyA. 
One year survival was 84% for Cy A and 95% for the FK 
506 group. The I-year tnfeClion-free rate was 46% for CyA 
and 61% for FK 506 group IP "" .32). The frequency of 
various infection categories IS shown 10 Table 2. Infections 
were also expressed as the number of episodes of infection 
per infected patient. Overall 50.9% of the Cy A group and 
38.6% of the FK 506 group had al least one IOfectlon 
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Table 2. P .. ~ of Im.cted Patient. and Number of 
Epi80dn per Infected PItIenta SubdIVided In 
~oflmKcuon 
P_PatMIIU ~lnfec:fffd 
Inrec.:t p .... 
CyA Fl( 506 CyA Fl( 506 
Baetenal 43 .• 2B.1 1.7 1.4 
Viral 24.S 19.3 1 .• 1.0 
Fungal 3B 3.5 1.0 1.S 
PmIDZOaI J.B 0 1.0 0 
Total 50.9 38.8 2.2 1.6 
episode with 2.1 and 1.6 episodes per infected patients. 
respectively. There was a trend toward a lower frequency 
of bacterial infections in the FK 506 group tP = .14). When 
bacteremias were analyzed separately. they were seen 
more frequently in the CyA group t26.4% vs 7.0%. P = 
.013). The most frequent pathogens isolated from blood 
were aerobic gram· positive cocci. especially Siaphyioc:oc' 
cus aureus and enterococci. Enterobacrer cloacae was the 
most frequent aerobic gram·negative isolate. Table 3 lists 
the overall infection epIsodes observed in the two groups. 
The most frequent Infection was cytomegalovirus (CMY) 
followed by Clostridium dif/icile colitis. wound infection. 
and bacterial pneumonia. There were a total of [5 episodes 
of symptomatic CMY in the CyA and 10 episodes in the 
FK 506 group with a frequency of 20.8% and 17.5%, 
respectively. The CMY experience in this trial is summa· 
rized separately. ~ 
Other factors that played a role in the development of 
infections were examined. There were eight patients in the 
CyA group and four pattents in FK 506 group who had 
more than one transplant operation. The infection rate in 
both groups was higher compared with patients with only 
one tr.1llsplant operatton, The use of OKT3 in the CyA 
group was 32.1% compared wuh [7.5% in the FK 506 
group (p = . (1), The infection rate was higher after OKT3 
Table 3. Nunm. of Irnction Epleodee and Number of p.uenta 
IntIct8d In the Two Group. 
No.Patiere No. Elliladea 
Typelnf_ CyA F1( 508 CyA FK506 
Pneumonia 3 J 3 5 
Wauna IntecllOn 5 2 7 2 
Pentonms J 3 J 3 
C. QIIicde COUtls 5 6 5 6 
CholangitiS 3 4 3 4 
Badenlmta 5 1 6 1 
Abdcmanal abSceSS 2 0 2 0 
~ 8 1 9 1 
SymplDmallC CMV 11 10 15 10 
SymplDmallC EBV 3 , J , 
InvasMt candidiaSIS 2 2 2 2 
HIStDOIasmOSIS 0 , 0 1 
P camI pneurnon.a 2 0 2 0 
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in both groups. The use of additional steroids in form of 
"bolus" or "recycle" was higher In the CyA group (75.5% 
vs 52.6%. P = .02). 
DISCUSSION 
We previously reported lower infection rates with the use 
of the new immunosuppressive drug FK 506 compared 
with historical controls.3 (n the current study we were able 
to compare infectious complications in a randomized trial 
using CyA and FK 506. Because 70% of the patients in the 
CyA ann were later placed on FK 506. the comparison in 
infection rates is between FK 506 patients on one side and 
CyA or "initially eyA" patients on the other. 
Although the types of infection were similar in the two 
groups. the frequency of bacterial infection was lower in 
the FK 506 group especially when bacteremias were 
analyzed separately. The reduced requirement for steroids 
and OKTI in the FK 506 group may explain the lower 
frequency of bacterial infections observed in this group. 
Most infection episodes occurred in patients who were 
initially placed on Cy A and later convened to FK 506. This 
group had many risk factors for development of infectious 
complications. Twenty·two percent of these patients un-
derwent retransplantation. 78% received additional ste· 
roids. and 38% received OKTI (vs 7%, 55%. and 17% in 
the FK 506 group, respectively). In the group randomized 
to FK 506. we were able to use reduced amount of 
immunosuppressive agents to conuol rejection and the 
rate of retransplantation was lower. These factors are 
known to increase the risk of infection in liver transplan-
tation, 
Symptomatic CMY infection was still the most frequent 
infection in both groups. however it was not associated 
with death in either group. Although the number of symp-
tomatic Epsteln·Barr virus (EBY) infections were equiva· 
lent in both groups. one death associated with posttrans· 
plantation lymphoproliferatlve disease IP'fLD) was seen In 
the CyA group. Invasive funga.ilnfections were assocIated 
with high monality rate in both groups with two deaths in 
each. Two patients developed mn~umlCvAlis carin;i pneu-
monia and both were not taXing prophylactic drugs. 
In summary. the use of FK 506 has not resulted in an 
increase in the infection rate. and by eliminating the need 
for augmented immunosuppressIon may actually result in a 
lower inCIdence of infections. 
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